Hughes & Company is focused exclusively on lower middle market healthcare software and technology-enabled service companies. The healthcare lower middle market is large, complicated and inefficient, which the Firm believes creates attractive investment opportunities. The Firm does not invest in clinical service, pre-revenue, pharmaceutical, biotechnology or highly capital intensive businesses.
Hughes & Company is an active, hands-on investor with a focus on helping build exceptional, enduring and valuable businesses. The team combines significant healthcare operating, strategy and business development experience with investment expertise. The Firm creates value for its stakeholders through multiple avenues including business development, team building, resource optimization, shared operating best practices and clear accountability.
We invest in growth and later stage companies with proven business models and sustainable margin structures
Market leadership potential in sustainable, growing healthcare niches
Attractive business model attributes
High barriers to entry
Opportunity for value creation through revenue and EBITDA growth
We typically invest between $5 million and $20 million per company.
Investments are structured to match each unique opportunity. We invest in:
Minority and majority control transactions
Growth equity, leveraged buyouts, spin-outs, and strategic combinations